RPG Life Sciences - Strong Business Aided By Its Iconic Brands Portfolio In Domestic Formulation: Nirmal Bang
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Nirmal Bang Report
We attended the RPG Life Sciences Ltd.'s Annual Investor Conference to understand the business model and the company’s future growth prospects.
We gather from the interaction that the company has a very strong business foundation on account of its iconic brands portfolio in the domestic formulation space.
These iconic brands give RPG Life Sciences an edge when it comes to relationships with the doctors.
The company has embarked on a journey to leverage this strong reputation and physician relationships for scaling up its domestic franchise through new product launches that cater to the same therapeutic areas where it already has a strong presence.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.